ATLP reported a beat on our revenue estimate, led by higher realizations and strong demand in Colors, Crop Protection (Bulk Actives and Polymers), and the Performance Materials business. EBITDA was also 11% beat with EBITDAM at 18.2%, +70bps QoQ), still low, owing to higher input and freight cost, but was weighed down by lower Pharmaceuticals demand in the Life Science segment. Although demand remained robust in the Crop Protection, the Bulk Actives business has helped the company achieve 36% EBIT growth in the Life Sciences segment....